Pfizer to achieve net-zero standard by 2040
Pfizer aims to achieve net-zero targets ten years earlier than the expectations of the Net-Zero Standard
Pfizer aims to achieve net-zero targets ten years earlier than the expectations of the Net-Zero Standard
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
The Portal BioRRAP will cater to all those seeking regulatory approval for biological research
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
Wearable patch sensors (smart patches) are rising in popularity, as they offer a wide range of options for medical diagnosis
The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.
Foundation S will incorporate as its cornerstone initiative the former Sanofi Espoir Foundation’s ‘My Child Matters’ program in childhood cancer
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
Subscribe To Our Newsletter & Stay Updated